GAMMA Investing »

C4 Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2k 217 5.70

More positions owned by GAMMA Investing

Apple Common Stock (AAPL)
Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding C4 Therapeutics

Soleus Capital Management
Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
OrbiMed Advisors
Morgan Stanley
Commodore Capital
Vanguard Group
Samlyn Capital
Bank of America Corporation
Adage Capital Partners GP
Geode Capital Management
Arrowpoint Asset Management
Silverarc Capital Management

View all funds holding C4 Therapeutics